NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts
- Resource Type
- Article
- Authors
- Zhang, Deyi; Harris, Hailey M.; Chen, Jonathan; Judy, Jen; James, Gabriella; Kelly, Aileen; McIntosh, Joel; Tenn-McClellan, Austin; Ambing, Eileen; Tan, Ying Siow; Lu, Hao; Gajewski, Stefan; Clifton, Matthew C.; Yung, Stephanie; Robbins, Daniel W.; Pirooznia, Mehdi; Skånland, Sigrid S.; Gaglione, Erika; Mhibik, Maissa; Underbayev, Chingiz; Ahn, Inhye E.; Sun, Clare; Herman, Sarah E. M.; Noviski, Mark; Wiestner, Adrian
- Source
- In Blood 30 March 2023 141(13):1584-1596
- Subject
- Immunobiology and Immunotherapy
Lymphoid Neoplasia
- Language
- ISSN
- 0006-4971